Mcphy Energy: Monthly Information Relating To The Total Number Of Voting Rights And Outstanding Shares (February 28, 2025)
| Date | Total number of outstanding shares | Total number of voting rights * | |
| Gross | Net | ||
| 28.02.2025 | 29,281,788 | 29,281,788 | 29,127,166 |
* Total number of voting rights (i) "gross" calculated on the basis of all the shares to which voting rights are attached, including those deprived of voting rights, (ii) "net" calculated on the basis of all the shares to which voting rights are attached after deduction of those deprived of voting rights
ABOUT MCPHY
Specialized in hydrogen production equipment, McPhy is contributing to the global deployment of low-carbon hydrogen as a solution for energy transition. With its complete range of products dedicated to the industrial, mobility and energy sectors, McPhy offers its customers turnkey solutions adapted to their applications in industrial raw material supply, recharging of fuel cell electric vehicles or storage and recovery of electricity surplus based on renewable sources. As designer, manufacturer and integrator of hydrogen equipment since 2008, McPhy has three development, engineering and production centers in Europe (France, Italy, Germany). Its international subsidiaries provide broad commercial coverage for its innovative hydrogen solutions. McPhy Energy is listed on Euronext Growth Paris (ISIN code: FR0011742329, ticker: ALMCP).
CONTACTS
| Investor Relations NewCap Emmanuel Huynh T. +33 (0)1 44 71 94 99 ... | Press Relations DGM Conseil Pascal Pogam T. +33 (0) 6 03 62 27 65 Henry Debreuilly T. +33 (0) 6 13 11 38 74 ... |
Follow us on
@McPhyEnergy
Attachment
-
McPhy_Déclaration mensuelle DDV (02.2025_VA

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment